Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human NEK2 Stable Cell Line

    [CAT#: S01YF-1023-PY24]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX399 Magic™ Human NEK2 in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;OCI-Ly3;SU-DHL-4
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Ocular Research;CNS Research
    Related Diseases
    Retinitis Pigmentosa 67; Retinitis Pigmentosa
    Gene ID
    Human:4751
    UniProt ID
    Human:P51955

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    NEK2, a serine/threonine kinase, is involved in various aspects of cancer development and treatment. In multiple myeloma, inhibiting NEK2 can reshape the tumor microenvironment by reducing tumor-associated macrophages and decreasing T cell exhaustion, leading to an enhanced anti-cancer immune response. In esophageal adenocarcinoma, NEK2 and other members of the NEK kinase family are upregulated, suggesting their role in tumorigenesis and progression. In lymphoma, NEK2 inhibition with NBI-961 has shown promising results by compromising cell fitness, inducing cell cycle arrest and apoptosis, and suppressing tumor growth. Additionally, NEK2 has been identified as a potential therapeutic target for cancer treatment, including in diffuse large B-cell lymphoma, where high NEK2 expression is associated with inferior overall survival. The inhibition of NEK2 may overcome tumor immune escape and support the development of anti-NEK2 therapeutic strategies. Overall, NEK2 plays a significant role in cancer biology and has potential applications as a target for cancer therapy.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human NEK2 Stable Cell Line (S01YF-1023-PY24). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Jordan Miller (Verified Customer)

    What is the primary function of NEK2 in cells? May 12 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    NEK2 is a serine/threonine-protein kinase that localizes to centrosomes and kinetochores, controlling centrosome separation and playing a critical role in cell cycle regulation. May 12 2020

    chat Taylor Miller (Verified Customer)

    What cellular abnormalities are linked to aberrant NEK2 regulation? Jun 06 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Aberrant regulation of NEK2 activity can lead to aneuploid defects characteristic of cancer cells. Jun 06 2023

    Published Data

    Fig.1 In OCI-Ly3 and SU-DHL-4, EdU-positive cells from NEK2 knockdown groups were found in regions with lower cell density than the control group.

    NEK2 actively fosters cell growth while suppressing programmed cell death. Displayed are illustrative visuals of EdU staining alongside corresponding statistical data concerning the rate of EdU-positive cells, serving as a demonstrative indicator of NEK2's augmentation of cellular proliferation (statistical significance denoted as *P < 0.05, **P < 0.01, ***P < 0.001, as determined by Student's t-test).

    Ref: Zhou, Lingna, et al. "NEK2 promotes cell proliferation and glycolysis by regulating PKM2 abundance via phosphorylation in diffuse large B-cell lymphoma." Frontiers in Oncology 11 (2021): 677763.

    Pubmed: 34168996

    DOI: 10.3389/fonc.2021.677763

    Research Highlights

    Lischer, Christopher; Bru, Heiko. "Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment." Cell reports. Medicine, 2023.
    In this article, Cheng et al. discuss the influence of social media on the mental well-being of adolescents. Through their examination, they highlight the potential negative effects that excessive social media use may have on teenage mental health. They also suggest possible interventions and strategies for parents, educators, and mental health professionals to mitigate these negative impacts and promote positive social media usage among teenagers. Their findings highlight the importance of addressing this issue and promoting healthy social media habits for teenagers.
    Lischer, Christopher; Bru, Heiko. "Breaking barriers: NEK2 inhibition shines in multiple myeloma treatment." Cell reports. Medicine, 2023.
    Pubmed: 37852178   DOI: 10.1016/j.xcrm.2023.101237

    Chen, Lei. et al. "Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus." Cancers, 2023.
    The incidence of esophageal adenocarcinoma (EAC) has rapidly increased in the past four decades, making it the most common type of esophageal cancer in the USA and Western countries. The NEK (Never in mitosis A (NIMA) related kinase) gene family, which consists of 11 serine/threonine kinases, has been implicated in the development and progression of various human cancers. However, the expression of NEKs in EAC and its precursor condition, Barrett's esophagus (BE), has not been thoroughly investigated. Through bioinformatic analysis of 10 databases, including TCGA and 9 GEO databases, we found significant upregulation of NEK2, NEK3, and NEK6 in EAC compared to normal esophagus samples. We also observed downregulation of NEK1 in EAC. These findings were substantiated by qRT-PCR, Western blotting, and immunohistochemistry analysis of NEK expression in EAC cell lines and primary EAC tissues. Our results suggest a potential role for NEK2, NEK3, and NEK6 in the development of EAC.
    Chen, Lei. et al. "Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett's Esophagus." Cancers, 2023.
    Pubmed: 37835513   DOI: 10.3390/cancers15194821

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare